Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Preclinical studies support development of G-3139 as chemosensitizer

Feb. 27, 1998

Taxotere approved in China

Feb. 27, 1998

Medivir studies new anticancer sterols

Feb. 27, 1998

Schering AG reports pure antiestrogens

Feb. 27, 1998

Oncologic Drugs Advisory Committee meets next month

Feb. 26, 1998

New mitomycin formulation now under FDA review

Feb. 26, 1998

Aminopterin enters phase II for endometrial cancer

Feb. 26, 1998

New anticancer agent capable of eluding tumor resistance mechanisms

Feb. 25, 1998

PI-88 one step closer to clinical testing

Feb. 24, 1998

DBD meets with FDA to discuss dibromodulcitol progress

Feb. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...